Leica Biosystems Launches New Digital Pathology Scanner and QC Software
The scanner targets mid-volume labs, while the new software automates slide quality control processes.
The scanner targets mid-volume labs, while the new software automates slide quality control processes.
The study consolidating data from six published studies confirms the test outperforms traditional pathology or clinical factors alone in identifying esophageal cancer risk.
The proposed order would shift these test systems to Class II with special controls, replacing the current PMA requirement for companion diagnostics and related oncology assays.
The integration is designed to bridge specimen grossing with digital pathology workflows for improved diagnostic accuracy and efficiency.
The Genius Digital Diagnostics System is now approved for both cell and tissue specimen imaging in the European Union.
The all-in-one diagnostic platform combines hematology, biochemistry, and immunoassay testing in a single run.
New plate-based multiplexing can profile up to 384 samples and 100 million cells per week.Â
The 2026 clinical lab fee schedule sets payment for CPT code 81195 at $1,853.22, up from $1,263.53 in 2025.
The qPCR-based test detects variants that increase risk of severe fluoropyrimidine chemotherapy toxicity.
The system is designed to handle more than 10,000 injections without cleaning and scan over 900 SRM transitions per second for high-throughput laboratories.
The exsig Mag RapidBead Pro kit features a four-step workflow that reduces extraction time to under 20 minutes.
UMBS-seq preserves DNA integrity while maintaining accuracy for cancer biomarker detection in liquid biopsies and tissue samples.
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.
Faster, more accurate testing is helping clinicians identify synthetic opioids sooner and treat overdoses more effectively.